Department of Chemistry, University of Modena and Reggio Emilia, Via G. Campi 183, 41100 Modena, Italy.
Eur J Med Chem. 2010 Nov;45(11):4746-60. doi: 10.1016/j.ejmech.2010.07.039. Epub 2010 Jul 27.
Inhibition of the 5-hydroxytryptamine receptor (5-HT(3)R), a member of the Cys-loop superfamily of Ligand-Gated Ion Channels (LGICs), has been recognized to have important antiemetic effects. With respect to the many other drugs already in use, such as the first generation 5-HT(3)R antagonist granisetron, palonosetron, a second generation antagonist, clearly demonstrates superior inhibition potency towards the 5-HT(3)Rs. Five different receptor monomers, the 5-HT(3)R A-E, have been identified although the A and B subunits are the only known to build functional receptors, the homopentameric 5-HT(3A)R and the heteropentameric 5-HT(3B-A)R (with BBABA subunit arrangement). At present, however, no three-dimensional structure has been reported for any of the 5-HT(3)R subunits. To understand the binding properties of agonists and antagonists, models of the extracellular portion of the 5-HT(3)R A and B subunits are built and assembled into the receptor (homo- and hetero-) pentameric structure on the basis of the known three-dimensional structure of the nicotinic-acetylcholine receptor (nACh-R). The results of docking studies of the natural agonist serotonin and the antagonists palonosetron and granisetron into the modelled homomeric and heteromeric 5-HT(3)R binding interfaces, provide a possible rationalization both of the higher potency of palonosetron with respect to other antagonists, and of its previously reported allosteric binding and positive cooperativity properties.
5-羟色胺受体(5-HT(3)R)是配体门控离子通道(LGIC)Cys 环超家族的成员,其抑制作用已被认为具有重要的止吐作用。与已经使用的许多其他药物(如第一代 5-HT(3)R 拮抗剂格拉司琼)相比,第二代拮抗剂帕洛诺司琼对 5-HT(3)R 表现出明显更高的抑制效力。虽然 A 和 B 亚基是唯一已知构建功能性受体的亚基,但已经鉴定出五个不同的受体单体,即 5-HT(3)R A-E。同五聚体 5-HT(3A)R 和异五聚体 5-HT(3B-A)R(具有 BBABA 亚基排列)。然而,目前尚未报道任何 5-HT(3)R 亚基的三维结构。为了了解激动剂和拮抗剂的结合特性,构建了 5-HT(3)R A 和 B 亚基胞外部分的模型,并根据已知的烟碱型乙酰胆碱受体(nACh-R)的三维结构将其组装到受体(同聚体和异聚体)五聚体结构中。将天然激动剂 5-羟色胺和拮抗剂帕洛诺司琼和格拉司琼对接研究的结果进入建模的同聚体和异聚体 5-HT(3)R 结合界面,为帕洛诺司琼相对于其他拮抗剂的更高效力以及其先前报道的变构结合和正协同作用特性提供了一种可能的合理化解释。